This result may reflect the complexity of the tumor microenvironment, while high PD-L1 expression is generally associated with enhanced sensitivity to immunotherapy, factors, such as an immunosuppressive microenvironment or tumor heterogeneity could limit therapeutic efficacy in this subgroup. Here, CD274 is linked to neoplasm.